SCHEMBL753039

SCHEMBL753039

COC(=O)c1ccc(Oc2ccc([C@@H](C)[C@@](O)(c3ccc(=O)n(C)c3)C(F)(F)F)c(Cl)c2)cc1Cl

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN8A Q9UQD0 1/20 0.34
SCN10A Q9Y5Y9 1/20 0.34
BAZ2B Q9UIF8 1/20 0.33
BAZ2A Q9UIF9 1/20 0.33
KDM4E B2RXH2 1/20 0.33
CYP1A2 P05177 1/20 0.32
CYP2C19 P33261 1/20 0.32
CFTR P13569 1/20 0.32
PDK2 Q15119 2/20 0.32
NR3C1 P04150 4/20 0.32
KCNH2 Q12809 2/20 0.32
HTR2A P28223 1/20 0.32
SLC6A4 P31645 1/20 0.32
PDE2A O00408 1/20 0.31
KMT2A Q03164 1/20 0.31
ATM Q13315 1/20 0.31
P2RX3 P56373 1/20 0.31
MRGPRX4 Q96LA9 1/20 0.31
HRH1 P35367 1/20 0.31
CCR3 P51677 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL480093 1.00 SCN8A (0.34) SCN8ASCN10ABAZ2BBAZ2AKDM4E
SCHEMBL754470 0.94 SCN8A (0.34) SCN8ASCN10ABAZ2BBAZ2AKDM4E
SCHEMBL480150 0.94 SCN8A (0.34) SCN8ASCN10ABAZ2BBAZ2AKDM4E
SCHEMBL480948 0.91 LMNA (0.37) PDK2NR3C1P2RX3PDK1PDK3
SCHEMBL753268 0.91 LMNA (0.37) PDK2NR3C1P2RX3PDK1PDK3
SCHEMBL754457 0.91 PDK2 (0.40) BAZ2BBAZ2AKDM4ECYP1A2CYP2C19
SCHEMBL734909 0.91 S1PR2 (0.34) SCN8ASCN10ABAZ2BBAZ2ANR3C1
SCHEMBL733268 0.91 PDK2 (0.40) BAZ2BBAZ2AKDM4ECYP1A2CYP2C19
SCHEMBL754450 0.91 S1PR2 (0.34) SCN8ASCN10ABAZ2BBAZ2ANR3C1
SCHEMBL480071 0.89 LMNA (0.34) CYP1A2CYP2C19CFTRPDK2PDE2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138189-B2 Substituted benzene compounds as modulators of the glucocorticoid receptor HOFFMAN-LA ROCHE INC. (US) 2012-03-20 US disclosed
US-8138189-B2 Substituted benzene compounds as modulators of the glucocorticoid receptor HOFFMAN-LA ROCHE INC. (US) 2012-03-20 US disclosed
US-20100249139-A1 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS HOFFMANN-LA ROCHE, INC. 2010-09-30 US disclosed
US-20100249139-A1 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS HOFFMANN-LA ROCHE, INC. 2010-09-30 US disclosed
WO-2010108902-A1 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2010-09-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100249139-A1 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS NR3C1, NR3C2, CRHR1 SCN8A 2137/4885SCN10A 1954/4885BAZ2B 4537/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.